new antiepileptic, Gabitril (tiagabine)

November 1997

Abbott is introducing a new antiepileptic, Gabitril (tiagabine). It's coming out now in the U.S...next year in Canada.

Gabitril will be used as add-on therapy for partial seizures.

It's thought to work by blocking the reuptake of GABA...the major inhibitory neurotransmitter in the CNS. The increased GABA levels "apply the brakes" to inhibit seizures.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

New technology is helping pharmacists provide pharmaceutical care
Parkinson Disease Two new drugs for Parkinson's just hit the market
Parkinson Disease Tasmar is the first in a new class
Osteoporosis Fosamax (alendronate) to PREVENT osteoporosis in postmenopausal women
Hepatitis C lamivudine (3TC) for chronic hepatitis B
Hepatitis C more attention these days on hepatitis C
Cholesterol Cardiem, a new supplement to lower cholesterol
Neurology & Pain Copaxone (glatiramer acetate) for multiple sclerosis
Neurology & Pain new antiepileptic, Gabitril (tiagabine)
Women's Health treating severe premenstrual symptoms with SSRIs
which vit E supplements are best
asking about alpha lipoic acid (thioctic acid)
Hypertension new angiotensin II antagonists
Famvir and Valtrex for long-term therapy
Combivir, the first combo tablet for HIV
The FDA will approve thalidomide
metered-dose inhalers (MDIs) instead of a nebulizer to treat ACUTE asthma or COPD
Practice You'll soon see ads for Zantac 75

new antiepileptic, Gabitril (tiagabine)

Practical advice for a better career, with unlimited access to CE

Table of Contents